Newsletter | April 4, 2024

04.04.24 -- A New Model Approach To Drug Shortage Prevention

FEATURED EDITORIAL

A New Model Approach To Drug Shortage Prevention

The ISPE's Drug Shortages Prevention Model revamps its predecessor, the more prescriptive Drug Shortages Prevention Plan, with a focus on 12 key performance areas.

2024 LIMS Trends

The laboratory information management system (LIMS) landscape in 2024 is a dynamic one, driven by accelerating advancements in technology and evolving industry needs. This article shares the four key trends.

Considerations For Robust Implementation Of The Multi-Attribute Method

USP experts explore implementation strategies for the multi-attribute method, including best practices summarized from the USP’s General Chapter <1060>.

INDUSTRY INSIGHTS

Mycoplasma Contamination In Biopharmaceutical Manufacturing

Examine how following strict laboratory practices and conducting routine testing for Mycoplasma contamination using nucleic acid-based assays ensures the production of safe, high-quality products.

Kick It Off Right: A Successful Cell Bank Manufacture

Learn about best practices for cell bank manufacturing, how to get the most out of your cell bank, the future of closed processing in line with Annex 1, and more.

NEWS HEADLINES

Biocon Biologics Enters A Long-Term Commercial Collaboration With Eris Lifesciences

Phase 3 Clinical Trial Completed In China For Boan Biotech’s Dulaglutide Injection BA5101

Bio-Thera Solutions Partners With Steincares To Market Two Biosimilars In LATAM

Fresenius Kabi & Formycon Reach Settlement Agreement For Ustekinumab Biosimilar Candidate

Biosimilars Forum Urges Congress To Support Free Market Competition & Lower Prescription Drug Prices For Patients By Reforming Pharmacy Benefit Managers

SOLUTIONS

Palltronic Flowstar V Filter Integrity Test Instrument